[Federal Register: January 25, 2005 (Volume 70, Number 15)]
[Notices]
[Page 3567-3568]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25ja05-69]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[Docket No. 030-33542]
Notice of Availability of Environmental Assessment and Finding of
No Significant Impact for License Amendment for Pharmacopeia,
Incorporated's Facility in Monmouth Junction, NJ
AGENCY: Nuclear Regulatory Commission.
ACTION: Notice of availability.
-----------------------------------------------------------------------
FOR FURTHER INFORMATION CONTACT: John Nicholson, Commercial and R&D
Branch, Division of Nuclear Materials Safety, Region I, 475 Allendale
Road, King of Prussia, Pennsylvania, 19406, telephone (610) 337-5236,
fax (610) 337-5269; or by email: jjn@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. Introduction
The Nuclear Regulatory Commission (NRC) is issuing a license
amendment to Pharmacopeia, Inc. for Materials License No. 29-30152-01,
to authorize release of its facility in Monmouth Junction, New Jersey
for unrestricted use. NRC has prepared an Environmental Assessment (EA)
in support of this action in accordance with the requirements of 10 CFR
part 51. Based on the EA, the NRC has concluded that a Finding of No
Significant Impact (FONSI) is appropriate. The amendment will be issued
following the publication of this Notice.
II. EA Summary
The purpose of the action is to authorize the release of the
licensee's Monmouth Junction, New Jersey facility for unrestricted use.
Pharmacopeia, Inc. was authorized by NRC from February 1999 to use
radioactive materials for research and development purposes at the
site. On April 28, 2004, Pharmacopeia, Inc. requested that NRC release
the facility for unrestricted use. Pharmacopeia, Inc. has conducted
surveys of the facility and provided information to the NRC to
demonstrate that the site meets the license termination criteria in
Subpart E of 10 CFR part 20 for unrestricted use. Pharmacopeia, Inc.
will continue licensed activities at another location, as authorized by
the license.
The NRC staff has prepared an EA in support of the license
amendment. The facility was remediated and surveyed prior to the
licensee requesting the license amendment. The NRC staff has reviewed
the information and final status survey submitted by Pharmacopeia, Inc.
Based on its review, the staff has determined that there are no
additional remediation activities necessary to complete the proposed
action. Therefore, the staff considered the impact of the residual
radioactivity at the facility and concluded that since the residual
radioactivity meets the requirements in Subpart E of 10 CFR Part 20, a
Finding of No Significant Impact is appropriate.
III. Finding of No Significant Impact
The staff has prepared the EA (summarized above) in support of the
license amendment to release the facility for unrestricted use. The NRC
staff has evaluated Pharmacopeia, Inc.''s request and the results of
the surveys and has concluded that the completed action complies with
the criteria in Subpart E of 10 CFR Part 20. The staff has found that
the environmental impacts from the action are bounded by the impacts
evaluated by NUREG-1496, Volumes 1-3, ``Generic Environmental Impact
Statement in Support of Rulemaking on Radiological Criteria for License
Termination of NRC-Licensed Facilities' (ML042310492, ML042320379, and
ML042330385). On the basis of the EA, the NRC has concluded that the
environmental impacts from the action are expected to be insignificant
and has determined not to prepare an environmental impact statement for
the action.
[[Page 3568]]
IV. Further Information
Documents related to this action, including the application for the
license amendment and supporting documentation, are available
electronically at the NRC's Electronic Reading Room at http://www.nrc.gov/reading-rm/adams.html.
From this site, you can access the
NRC's Agencywide Document Access and Management System (ADAMS), which
provides text and image files of NRC's public documents. The ADAMS
accession numbers for the documents related to this Notice are: The
Environmental Assessment (ML043340345), Letter dated April 28, 2004,
requesting the amendment (ML041330096), Letter dated September 14,
2004, providing additional information (ML042720160), and Letter from
New Jersey Department of Environmental Protection dated November 15,
2004 (ML043290297). Please note that on October 25, 2004, the NRC
terminated public access to ADAMS and initiated an additional security
review of publicly available documents to ensure that potentially
sensitive information is removed from the ADAMS database accessible
through the NRC's web site. Interested members of the public may obtain
copies of the referenced documents for review and/or copying by
contacting the Public document Room pending resumption of public access
to ADAMS. The NRC Public documents Room is located at NRC Headquarters
in Rockville, MD, and can be contacted at (800) 397-4209 or (301) 415-
4737, or by email to pdr@nrc.gov. The PDR reproduction contractor will
copy documents for a fee. The PDR is open from 7:45 a.m. to 4:15 p.m.,
Monday through Friday, except on Federal holidays.
Dated at King of Prussia, Pennsylvania, this 14 day of January,
2005.
For the Nuclear Regulatory Commission.
James Dwyer,
Chief, Commercial and R&D Branch, Division of Nuclear Materials Safety
Region I.
[FR Doc. 05-1282 Filed 1-24-05; 8:45 am]
BILLING CODE 7590-01-P